Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity

PURPOSE: Neoadjuvant radiochemotherapy (RCTH) is proven to be highly effective in the treatment of esophageal cancer (EC). We investigated oncological outcome and morbidity in patients treated with a modified CROSS protocol followed by esophagectomy at our institution. METHODS: Patients with EC rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Paireder, Matthias, Jomrich, Gerd, Kristo, Ivan, Asari, Reza, Rieder, Erwin, Beer, Andrea, Ilhan-Mutlu, Aysegül, Preusser, Matthias, Schmid, Rainer, Schoppmann, Sebastian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449995/
https://www.ncbi.nlm.nih.gov/pubmed/32055873
http://dx.doi.org/10.1007/s00066-020-01594-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449995/
https://www.ncbi.nlm.nih.gov/pubmed/32055873
http://dx.doi.org/10.1007/s00066-020-01594-z

Ejemplares similares